Is there a future for clinical use of bispecific monoclonal antibodies?

被引：0
|
作者：
Warnaar, SO [1 ]
机构：
[1] CENTOCOR BV,LEIDEN,NETHERLANDS
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：300 / 300
页数：1
相关论文
共 50 条
  • [21] CHIMERIC HUMAN MOUSE BISPECIFIC MONOCLONAL-ANTIBODIES
    SONGSIVILAI, S
    CLISSOLD, PM
    LACHMANN, PJ
    BRITISH JOURNAL OF CANCER, 1990, 62 (03) : 486 - 486
  • [22] BISPECIFIC MONOCLONAL-ANTIBODIES FROM HYBRID HYBRIDOMAS
    SURESH, MR
    CUELLO, AC
    MILSTEIN, C
    METHODS IN ENZYMOLOGY, 1986, 121 : 210 - 228
  • [23] PRODUCTION OF MONOCLONAL-ANTIBODIES TO THEOPHYLLINE FOR CLINICAL USE
    GELTOSKY, JE
    CLINICAL CHEMISTRY, 1983, 29 (06) : 1201 - 1201
  • [24] Viral infections associated with the clinical use of monoclonal antibodies
    Gentile, G.
    Foa, R.
    CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (12) : 1769 - 1775
  • [25] IMPORTANCE AND USE OF MONOCLONAL-ANTIBODIES IN CLINICAL MICROBIOLOGY
    BORKHARDT, HL
    MULLER, WA
    ZEITSCHRIFT FUR KLINISCHE MEDIZIN-ZKM, 1989, 44 (13): : 1081 - 1083
  • [26] Single-step purification of bispecific monoclonal antibodies for immunotherapeutic use by hydrophobic interaction chromatography
    Manzke, O
    Tesch, H
    Diehl, V
    Bohlen, H
    JOURNAL OF IMMUNOLOGICAL METHODS, 1997, 208 (01) : 65 - 73
  • [27] The present and future of bispecific antibodies for cancer therapy
    Klein, Christian
    Brinkmann, Ulrich
    Reichert, Janice M.
    Kontermann, Roland E.
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (04) : 301 - 319
  • [28] Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment
    Yu, Shengnan
    Liu, Qian
    Han, Xinwei
    Qin, Shuang
    Zhao, Weiheng
    Li, Anping
    Wu, Kongming
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2017, 6
  • [29] Bispecific antibodies and ADCs Once and future kings?
    Reichert, Janice M.
    MABS, 2011, 3 (04) : 329 - 330
  • [30] Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment
    Shengnan Yu
    Qian Liu
    Xinwei Han
    Shuang Qin
    Weiheng Zhao
    Anping Li
    Kongming Wu
    Experimental Hematology & Oncology, 6
12345